These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33190255)

  • 1. Bone marrow transplantation in the United Kingdom - past, present and future.
    Barrett J; Craddock C
    Br J Haematol; 2020 Nov; 191(4):612-616. PubMed ID: 33190255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the field of hematology in the last 100 years: Hematopoietic stem cell transplantation].
    Harada M
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2019-23. PubMed ID: 12187668
    [No Abstract]   [Full Text] [Related]  

  • 3. Thirty Years of Bone Marrow Transplantation in the Singapore General Hospital.
    Phipps C; Ho AY; Linn YC; Gopalakrishnan S; Ang AL; Lee JJ; Ng HY; Lim FW; Goh PS; Loh YS; Tan PH; Koh LP; Koh MB; Lee LH; Goh YT; Ong YW; Hwang WY
    Ann Acad Med Singap; 2016 Jul; 45(7):315-7. PubMed ID: 27523512
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow and haematopoietic stem cell transplantation in Poland.
    Hołowiecki J
    Przegl Lek; 2000; 57 Suppl 1():17-23. PubMed ID: 10822989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity survey and historical perspective of autologous stem cell transplantation in Europe.
    Gratwohl A
    Semin Hematol; 2007 Oct; 44(4):220-6. PubMed ID: 17961720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.
    Steering Committee Of The Blood And Marrow Transplant Clinical Trials Network
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1747-1757. PubMed ID: 27418009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematopoietic cell transplantation: some historic milestones].
    Plagne R; Maraninchi D
    Bull Cancer; 2001 Sep; 88(9):822-5. PubMed ID: 11604352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
    Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: a historical perspective.
    Buckner CD
    J Hematother; 1999 Jun; 8(3):233-6. PubMed ID: 10417045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic-cell transplantation at 50.
    Appelbaum FR
    N Engl J Med; 2007 Oct; 357(15):1472-5. PubMed ID: 17928594
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.
    Slavin S; Or R; Aker M; Shapira MY; Panigrahi S; Symeonidis A; Cividalli G; Nagler A
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S79-84. PubMed ID: 11587373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic stem-cell transplantation: a long way, from animal models to a standard treatment in human].
    León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):129-31. PubMed ID: 16524050
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.
    Ferrara JL
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):149-53. PubMed ID: 24239651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
    Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
    JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT).
    Vindeløv L
    Eur J Haematol; 2001 Feb; 66(2):73-82. PubMed ID: 11168513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases].
    Gratwohl A
    Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase inhibitor ZVAD-fmk facilitates engraftment of donor hematopoietic stem cells in intra-bone marrow-bone marrow transplantation.
    Imai Y; Adachi Y; Shi M; Shima C; Yanai S; Okigaki M; Yamashima T; Kaneko K; Ikehara S
    Stem Cells Dev; 2010 Apr; 19(4):461-8. PubMed ID: 19686047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.